標(biāo)題: Titlebook: Clinical Cases in Phototherapy; John Koo,Mio Nakamura Book 2017 Springer International Publishing AG 2017 Phototherapy.Ultraviolet B.PUVA. [打印本頁(yè)] 作者: VIRAL 時(shí)間: 2025-3-21 16:54
書目名稱Clinical Cases in Phototherapy影響因子(影響力)
書目名稱Clinical Cases in Phototherapy影響因子(影響力)學(xué)科排名
書目名稱Clinical Cases in Phototherapy網(wǎng)絡(luò)公開(kāi)度
書目名稱Clinical Cases in Phototherapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Clinical Cases in Phototherapy被引頻次
書目名稱Clinical Cases in Phototherapy被引頻次學(xué)科排名
書目名稱Clinical Cases in Phototherapy年度引用
書目名稱Clinical Cases in Phototherapy年度引用學(xué)科排名
書目名稱Clinical Cases in Phototherapy讀者反饋
書目名稱Clinical Cases in Phototherapy讀者反饋學(xué)科排名
作者: ACE-inhibitor 時(shí)間: 2025-3-21 23:13
Phototherapy-Induced Iatrogenic Polymorphous Light Eruption,作者: Locale 時(shí)間: 2025-3-22 01:59
Combing Phototherapy with Acitretin: Re-PUVA and Re-UVB,作者: Heterodoxy 時(shí)間: 2025-3-22 07:57 作者: cluster 時(shí)間: 2025-3-22 09:44 作者: 儲(chǔ)備 時(shí)間: 2025-3-22 14:39 作者: 儲(chǔ)備 時(shí)間: 2025-3-22 19:40 作者: 騙子 時(shí)間: 2025-3-23 01:17 作者: 共同確定為確 時(shí)間: 2025-3-23 04:28 作者: 英寸 時(shí)間: 2025-3-23 06:04 作者: Vital-Signs 時(shí)間: 2025-3-23 10:06 作者: 導(dǎo)師 時(shí)間: 2025-3-23 15:31
Retinal Stem Cell Transplantation for Rat,nodularis, and chronic pruritus. Coal tar is speculated to be an anti-inflammatory and a photosensitizer that can increase the effectiveness of phototherapy. In the Goeckerman regimen, patients first undergo UVB phototherapy per protocol. Then their body is covered in crude coal tar under plastic oc作者: 乳白光 時(shí)間: 2025-3-23 19:25
Retinal Stem Cell Transplantation for Rat,s near the individual’s minimal erythema dose (MED) or the lowest dose of light at which the skin turns erythematous or pink. It is important to remember that the every patient has his/her own unique dosimetry threshold and patients should be treated appropriately aggressively for optimal response t作者: Ornithologist 時(shí)間: 2025-3-23 23:41 作者: tackle 時(shí)間: 2025-3-24 03:45
H. Duane Smith,Clive D. Jorgensenother words, the patient appears to be photosensitive without any underlying cause. In the case of initiation burn, it is important not to jump to the conclusion that the patient is not a candidate for phototherapy or has “failed” phototherapy. Instead, it is recommended to deliberately continue pho作者: cajole 時(shí)間: 2025-3-24 08:39 作者: 完整 時(shí)間: 2025-3-24 11:13 作者: OTHER 時(shí)間: 2025-3-24 16:50 作者: 含鐵 時(shí)間: 2025-3-24 19:21
https://doi.org/10.1007/978-94-017-2919-2any type of phototherapy. Phototherapy, in reality, is a “double-edged sword” as it can either help or aggravate inflammation. If an intensely inflamed patient were to receive phototherapy by error, the intensity of inflammation can become so severe to the point that the patient may have to be hospi作者: 教育學(xué) 時(shí)間: 2025-3-25 00:23
https://doi.org/10.1007/978-94-017-2919-2but treatment response may be poor on the distal extremities. In such a case, the two-step approach can be utilized. In the two-step approach, the patient will first receive phototherapy as usual to the whole body for overall exposure, followed by a second additional treatment to the extremities whi作者: 表皮 時(shí)間: 2025-3-25 06:33 作者: CHAR 時(shí)間: 2025-3-25 07:34 作者: 爭(zhēng)吵 時(shí)間: 2025-3-25 12:36
La deuxième période parisienne (1861)penetrate. Topical retinoids (tazoratene) and keratolytics (salicylic acid and lactic acid) can help reduce scale. Coal tar and anthralin, although messy and more difficult to use, can also increase the effectiveness of phototherapy as demonstrated in the Goeckerman regimen and Ingram regimen, respe作者: outskirts 時(shí)間: 2025-3-25 16:12
Le séjour à Toulouse (1852–1861)be combined safely and effectively. Extremely rarely, methotrexate can induce an acute or delayed phototoxic reaction following phototherapy. In order to minimize this risk, there should be maximum amount of time between the dose of methotrexate and the next phototherapy session. Just like with othe作者: 離開(kāi)就切除 時(shí)間: 2025-3-25 21:50
La deuxième période parisienne (1861)sis and atopic dermatitis. “Cooling down” severely inflamed skin is necessary prior to initiation phototherapy. When patients cannot be “cooled down” with topical corticosteroids alone, cyclosporine is an excellent option provided that the patient is generally healthy and does not have any contraind作者: 被告 時(shí)間: 2025-3-26 02:22
Clinical Cases in Phototherapy978-3-319-51599-1Series ISSN 2730-6178 Series E-ISSN 2730-6186 作者: 笨拙的我 時(shí)間: 2025-3-26 07:34
https://doi.org/10.1007/978-94-017-2919-2udies point that NB-UVB may be more effective than BB-UVB, when a patient cannot tolerate NB-UVB, BB-UVB is a good alternative treatment option. Likewise, patients who cannot tolerate BB-UVB may be able to tolerate NB-UVB.作者: otic-capsule 時(shí)間: 2025-3-26 09:45
https://doi.org/10.1007/978-94-017-2919-2but treatment response may be poor on the distal extremities. In such a case, the two-step approach can be utilized. In the two-step approach, the patient will first receive phototherapy as usual to the whole body for overall exposure, followed by a second additional treatment to the extremities while covering the rest of the body.作者: 爭(zhēng)吵加 時(shí)間: 2025-3-26 13:54
La deuxième période parisienne (1861)penetrate. Topical retinoids (tazoratene) and keratolytics (salicylic acid and lactic acid) can help reduce scale. Coal tar and anthralin, although messy and more difficult to use, can also increase the effectiveness of phototherapy as demonstrated in the Goeckerman regimen and Ingram regimen, respectively.作者: flammable 時(shí)間: 2025-3-26 19:10
John Koo,Mio NakamuraContains real-life scenarios of patient cases in which phototherapy is an appropriate treatment option for the specific skin condition presented, followed by detailed discussion on management of these作者: 終端 時(shí)間: 2025-3-27 00:26 作者: 協(xié)奏曲 時(shí)間: 2025-3-27 01:56
Qiquan Sun MD, PhD,Xian Chang Li MD, PhDe times per week with increasing doses as tolerated. Results are typically observed after 10–12 treatment sessions. Duration of remission is approximately 3–6 months. Side effects include erythema, burning, blistering, and hyperpigmentation.作者: 敘述 時(shí)間: 2025-3-27 08:31 作者: nautical 時(shí)間: 2025-3-27 13:29 作者: 寡頭政治 時(shí)間: 2025-3-27 16:40
H. Duane Smith,Clive D. Jorgensentotherapy with the highest amount of light the patient can tolerate, even if this is a very low dose. This allows the skin to desensitize, harden, or get used to the light, and oftentimes the patient can eventually tolerate doses of light per the usual protocol.作者: GRUEL 時(shí)間: 2025-3-27 19:29 作者: HAIL 時(shí)間: 2025-3-28 01:27 作者: Tidious 時(shí)間: 2025-3-28 03:36 作者: 果仁 時(shí)間: 2025-3-28 07:38 作者: violate 時(shí)間: 2025-3-28 10:51 作者: 諷刺 時(shí)間: 2025-3-28 17:04
La deuxième période parisienne (1861)ications to cyclosporine therapy. After completing the cyclosporine “cool down”, patients can be started on phototherapy using a very conservative dosimetry protocol. After initiating phototherapy, cyclosporine can be slowly tapered off while maintaining treatment response with phototherapy.作者: 決定性 時(shí)間: 2025-3-28 20:17 作者: 不能妥協(xié) 時(shí)間: 2025-3-29 00:22
Avoiding Undertreatment with Phototherapy,o therapy. Furthermore, at least four to 6 weeks of phototherapy is commonly required to see the initial positive effects of phototherapy. Drastic improvement will likely take approximately 30 treatments or 10–12 weeks. It is important not to prematurely give up on phototherapy.作者: WAG 時(shí)間: 2025-3-29 06:08
,“Erythemogenic” Phototherapy for Select Patients Who Need It,n in order to maximize the speed of improvement and overall efficacy. This strategy can also be used if the sub-erythemogenic dosimetry strategy leads to “stalemate” at a point of improvement that is less than satisfactory for the patient.作者: Cumulus 時(shí)間: 2025-3-29 08:26 作者: 浮夸 時(shí)間: 2025-3-29 13:36 作者: cutlery 時(shí)間: 2025-3-29 18:25 作者: Urologist 時(shí)間: 2025-3-29 23:11 作者: 驕傲 時(shí)間: 2025-3-30 03:53
Phototherapy in the Setting of Photosensitizing Medications,ients can still undergo phototherapy. Patients on photosensitizing medications are treated using the protocol of one skin type below their actual skin type. When a photosensitizing medication is added during the course of phototherapy, the dose of light should be reduced by 50% and increased as tolerated.作者: 類型 時(shí)間: 2025-3-30 05:34 作者: Formidable 時(shí)間: 2025-3-30 11:53
,Combining Phototherapy with Cyclosporine “Cool Down”,ications to cyclosporine therapy. After completing the cyclosporine “cool down”, patients can be started on phototherapy using a very conservative dosimetry protocol. After initiating phototherapy, cyclosporine can be slowly tapered off while maintaining treatment response with phototherapy.作者: 吵鬧 時(shí)間: 2025-3-30 15:23 作者: 含糊 時(shí)間: 2025-3-30 20:28
Fabien Delerue,Fernando Benavides as tolerated. Phototherapy is extremely safe and effective. Approximately 70% of patients with moderate to severe psoriasis achieve at least 75% improvement of their psoriasis over 12 weeks. Common side effects include erythema, burning, and tanning.作者: Manifest 時(shí)間: 2025-3-30 23:35
Retinal Stem Cell Transplantation for Rat,therapies. For example, 100% of patients with severe psoriasis achieve 75% improvement or better from baseline by 12 weeks. Side effects include those of phototherapy (erythema, burning, and tanning), as well as irritation and folliculitis from tar products.作者: TEM 時(shí)間: 2025-3-31 02:56
Ultraviolet B Phototherapy for the Treatment of Moderate to Severe Psoriasis, as tolerated. Phototherapy is extremely safe and effective. Approximately 70% of patients with moderate to severe psoriasis achieve at least 75% improvement of their psoriasis over 12 weeks. Common side effects include erythema, burning, and tanning.作者: BOAST 時(shí)間: 2025-3-31 06:24 作者: 不自然 時(shí)間: 2025-3-31 10:30 作者: 腐蝕 時(shí)間: 2025-3-31 14:05
Le séjour à Toulouse (1852–1861) to minimize this risk, there should be maximum amount of time between the dose of methotrexate and the next phototherapy session. Just like with other photosensitizing medications, minimizing blood levels of the medication at the time of phototherapy results in the lowest risk of phototoxicity.作者: 蔓藤圖飾 時(shí)間: 2025-3-31 18:42
Combining Phototherapy with Methotrexate, to minimize this risk, there should be maximum amount of time between the dose of methotrexate and the next phototherapy session. Just like with other photosensitizing medications, minimizing blood levels of the medication at the time of phototherapy results in the lowest risk of phototoxicity.作者: BOGUS 時(shí)間: 2025-3-31 23:37 作者: invert 時(shí)間: 2025-4-1 05:19 作者: 字的誤用 時(shí)間: 2025-4-1 06:42 作者: Itinerant 時(shí)間: 2025-4-1 10:39 作者: Outwit 時(shí)間: 2025-4-1 17:27
PUVA for the Treatment of Moderate to Severe Psoriasis,tion with ultraviolet A (UVA) phototherapy. PUVA is used to treat moderate to severe psoriasis, generalized psoriasis, or psoriasis that is unresponsive to topical treatments. In systemic PUVA, patients take oral methoxsalen and are subsequently exposed to UVA. In topical and bath PUVA, patients exp作者: Mirage 時(shí)間: 2025-4-1 21:20
